XML 67 R45.htm IDEA: XBRL DOCUMENT
v3.20.2

Equity Awards and Instruments (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2020 | Dec. 31, 2019
Share-based Payment Arrangement [Abstract] |  |
Schedule of Options | The following is a summary of option activity under the Company's applicable equity incentive plans and after giving effect to the $1.50 downward exercise price adjustment as a result of the Special Dividend:
|  |  |  | Exercise Price Per Share
|  | Options |  |  |  | Weighted
|  | Outstanding |  | Range |  | Average
Balance, December 31, 2019 |  | 18,691,667 |  | $2.00 – $5.74 |  | $ | 4.47
Option activity: |  |  |  |  |  |  |
Granted |  | 10,000 |  | 9.34 |  |  | 9.34
Exercised |  | (4,864,944) |  | 2.00 – 5.74 |  |  | 3.37
Canceled |  | (223,250) |  | 2.00 – 9.34 |  |  | 5.30
Balance, September 30, 2020 |  | 13,613,473 |  | $3.73 – $5.74 |  | $ | 4.85
The following is a summary of options outstanding and exercisable by exercise price under the Company's applicable equity incentive plans as of September 30, 2020 and after giving effect to the $1.50 downward exercise price adjustment as a result of the Special Dividend:
|  |  |  | Weighted |  |
|  |  |  | Remaining |  |
|  | Number of |  | Contractual |  |
Exercise |  | Options |  | Life |  |
Prices |  | Outstanding |  | (in years) |  | Exercisable
$3.73 – $4.00 |  | 5,407,315 |  | 1.07 |  | 4,424,881
4.01 – 5.74 |  | 8,206,158 |  | 3.08 |  | 2,536,658
Total |  | 13,613,473 |  |  |  | 6,961,539
For the year ended December 31, 2019 and the nine months ended September 30, 2020, the Company received cash proceeds of $3,612 and $7,776, respectively, related to the exercise of stock options. The following is a summary of the intrinsic value of options outstanding and exercisable under the Company's applicable equity incentive plans as of September 30, 2020 and after giving effect to the $1.50 downward exercise price adjustment as a result of the Special Dividend:
|  |  |  |  |  |  |  |  |  | Weighted
|  |  |  | Weighted |  |  |  |  | Remaining
|  |  |  | Average |  | Aggregate |  | Contractual
|  | Number of |  | Exercise |  | Intrinsic |  | Life
|  | Options |  | Price |  | Value |  | (in years)
Options as of September 30, 2020 |  |  |  |  |  |  |  |  |  |
Outstanding |  | 13,613,473 |  | $ | 4.85 |  | $ | 361,441 |  | 2.3
Exercisable |  | 6,961,539 |  | $ | 4.40 |  | $ | 187,962 |  | 1.7
|  |  |  | Exercise Price Per Share
|  | Options |  |  |  |  |  |  |  | Weighted
|  | Outstanding |  | Range | Average
Balance, December 31, 2017 |  | 18,629,380 |  | $ | 0.31 | - | $ | 5.38 |  | $ | 3.72
Option activity: |  |  |  |  |  |  |  |  |  |  |
Granted |  | 5,126,000 |  |  | 6.81 | - |  | 8.67 |  |  | 6.81
Exercised |  | (3,738,182) |  |  | 0.31 | - |  | 5.38 |  |  | 1.89
Canceled |  | (502,750) |  |  | 0.31 | - |  | 8.67 |  |  | 5.04
Balance, December 31, 2018 |  | 19,514,448 |  | $ | 1.79 | - | $ | 6.81 |  | $ | 4.85
Option activity: |  |  |  |  |  |  |  |  |  |  |
Granted |  | 4,826,000 |  |  |  |  |  | 7.24 |  |  | 7.24
Exercised |  | (4,731,158) |  |  | 1.79 | - |  | 6.81 |  |  | 2.68
Canceled |  | (917,623) |  |  | 1.79 | - |  | 7.24 |  |  | 5.82
Balance, December 31, 2019 |  | 18,691,667 |  | $ | 3.50 | - | $ | 7.24 |  | $ | 5.97
The following is a summary of options outstanding and exercisable by exercise price as of December 31, 2019:
|  |  |  | Weighted |  |
|  | Number of |  | Remaining |  |
|  | Options |  | Contractual |  |
Exercise Prices |  | Outstanding |  | Life (in years) |  | Exercisable
$3.50 – $4.00 |  | 1,978,256 |  | 0.39 |  | 1,978,256
4.01 – 6.00 |  | 7,450,203 |  | 1.78 |  | 4,469,866
$6.01 – $7.24 |  | 9,263,208 |  | 3.82 |  | 1,125,708
Total |  | 18,691,667 |  |  |  | 7,573,830
The following is a summary of the intrinsic value of options outstanding and exercisable as of December 31, 2019:
|  |  |  |  |  |  |  |  |  | Weighted
|  |  |  | Weighted |  | Aggregate |  | Remaining
|  | Number of |  | Average |  | Intrinsic |  | Contractual
|  | Options |  | Exercise Price |  | Value |  | Life (in years)
Options as of December 31, 2019 |  |  |  |  |  |  |  |  |  |
Outstanding |  | 18,691,667 |  | $ | 5.97 |  | $ | 91,028 |  | 2.6
Exercisable |  | 7,573,830 |  | $ | 5.05 |  | $ | 43,852 |  | 1.6
Schedule of assumptions used to estimate the fair value of the share options granted |
|  | Year Ended |  | Nine Months Ended |
|  | December 31, |  | September 30, |
|  | 2019 |  | 2020 |
Expected volatility |  |  | 29.57 | % |  | 31.04 | %
Expected dividend yield |  |  | 1.38 | % |  | 1.11 | %
Risk-free interest rate |  |  | 2.48 | % |  | 1.31 | %
Expected term (in years) |  |  | 3.75 |  |  | 3.75 |
Weighted average grant date fair value of options issued |  | $ | 1.66 |  | $ | 2.49 |
|  |  | Year Ended December 31, |
|  |  | 2018 |  |  | 2019 |
Expected volatility |  |  | 26.32% – 27.18 | % |  |  | 29.57 | %
Expected dividend yield |  |  | 1.18 | % |  |  | 1.38 | %
Risk-free interest rate |  |  | 2.40 | % |  |  | 2.48 | %
Expected term (in years) |  |  | 3.75 |  |  |  | 3.75 |
Weighted average grant date fair value of options issued |  | $ | 1.46 |  |  | $ | 1.66 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration